From February 11 to 21, 2020: join the AGM e-convocation and support cancer research
You are a registered shareholder of Natixis and have not yet opted for the e-convocation to Shareholders’ General Meetings? You wish to do a good deed in favor of cancer control? Take advantage of the new e-consent campaign to switch to the digital version of the brochure to the AGM and its documentation.
For each new subscription, €4 will be donated to the benefit of cancer research conducted by the teams of Gustave Roussy. In this way, you are doing something for the environment by avoiding the printing of documentation and contributing to the advancement of cancer research.
The e-consent campaign is launched this week by the Individual Shareholder Relations team. By giving your agreement, this digital convening method will become effective as of the next General Meeting to be held on 20 May 2020 at 3 p.m. at the Palais Brongniart in Paris.
Up to 30,000 Natixis shareholders have already taken the digital shift by giving their approval. What about you?